Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,320 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC

NCT00000999

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • LaJolla Veterans Administration Med Ctr La Jolla, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

NCT00000753

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States
  • Washington U CRS St Louis, Missouri, United States
View Trial Details
Completed

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

NCT00000848

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +20 more
Locations
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 16 locations
View Trial Details
Completed

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

NCT00000892

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Willow Clinic Menlo Park, California, United States
View all 45 locations
View Trial Details
Completed

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

NCT00000771

Conditions
Acquired Immunodeficiency Syndrome, Animal Diseases, Blood-Borne Infections, +24 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

NCT00001043

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

NCT00000774

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • San Francisco Gen. Hosp. San Francisco, California, United States
View all 37 locations
View Trial Details
Completed

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

NCT00001042

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details

Related conditions